Research map: Antimicrobial resistance in Neisseria gonorrhoeae isolates at the Bangrak STIs Center, Bangkok, Thailand and WGS of antimicrobial-resistant isolates, 2018–23

Back to the article

Papers in this map

  1. Update to CDC's Treatment Guidelines for Gonococcal Infection, 2020 · Sancta B. St. Cyr · 2020 · 432 citations · Cited by this paper
  2. Novel EUCAST-approved quality control range for Escherichia coli ATCC® 25922 and cefoperazone 30 µg discs · 2026 · Related
  3. Gonorrhoea treatment failure caused by a Neisseria gonorrhoeae strain with combined ceftriaxone and high-level azithromycin resistance, England, February 2018 · David W. Eyre · 2018 · 378 citations · Cited by this paper
  4. Antifungal susceptibility profiles of clinical and environmental Scedosporium and Lomentospora isolates from Taiwan: focus on olorofim activity and phylogenetic heterogeneity · 2026 · Related
  5. 2020 European guideline for the diagnosis and treatment of gonorrhoea in adults · Magnus Unemo · 2020 · 246 citations · Cited by this paper
  6. Mutation-driven alterations in the AcrB efflux pump modulate antibiotic resistance in Klebsiella pneumoniae · 2026 · Related
  7. Public health surveillance of multidrug-resistant clones of Neisseria gonorrhoeae in Europe: a genomic survey · Simon R. Harris · 2018 · 219 citations · Cited by this paper
  8. Effect of adjunctive inhalation on the association between plasma AUC/MIC of polymyxin B and clinical efficacy in MDR gram-negative infections · 2026 · Related
  9. New Ceftriaxone- and Multidrug-Resistant Neisseria gonorrhoeae Strain with a Novel Mosaic penA Gene Isolated in Japan · Shu‐ichi Nakayama · 2016 · 217 citations · Cited by this paper
  10. Paediatric outpatient antibiotic utilization patterns and use of healthcare services before, during and after the COVID-19 pandemic: interrupted time series analysis using data from Norway and Japan · 2026 · Related
  11. Antimicrobial treatment and resistance in sexually transmitted bacterial infections · Jørgen Skov Jensen · 2024 · 132 citations · Cited by this paper
  12. Quinolones and risk of haemolysis in patients with glucose-6-phosphate dehydrogenase deficiency: a nationwide retrospective active-comparator cohort study · 2026 · Related
  13. Microbiological Analysis from a Phase 2 Randomized Study in Adults Evaluating Single Oral Doses of Gepotidacin in the Treatment of Uncomplicated Urogenital Gonorrhea Caused by Neisseria gonorrhoeae · Nicole E. Scangarella-Oman · 2018 · 109 citations · Cited by this paper
  14. Virological failure and resistance emergence during treatment with bictegravir/emtricitabine/tenofovir alafenamide or dolutegravir/lamivudine in people living with HIV without prior resistance mutations: a real-world study · 2026 · Related
  15. Europe-wide expansion and eradication of multidrug-resistant Neisseria gonorrhoeae lineages: a genomic surveillance study · Leonor Sánchez-Busó · 2022 · 98 citations · Cited by this paper
  16. Predictive performance of an antibiotic precision dosing software program in critically ill adults with infection · 2026 · Related
  17. In vitro activity of the novel triazaacenaphthylene gepotidacin (GSK2140944) against MDR Neisseria gonorrhoeae · Susanne Jacobsson · 2018 · 91 citations · Cited by this paper
  18. Outcomes of ceftriaxone 2 g versus 1 g daily in hospitalized patients with pneumonia: a nationwide retrospective cohort study-right-to-reply · 2026 · Related
  19. Oral gepotidacin for the treatment of uncomplicated urogenital gonorrhoea (EAGLE-1): a phase 3 randomised, open-label, non-inferiority, multicentre study · Jonathan D. C. Ross · 2025 · 90 citations · Cited by this paper
  20. Evaluation of in vitro synergy of cefepime/enmetazobactam combined with aztreonam against metallo-β-lactamase-producing Enterobacterales · 2026 · Related
  21. Ceftriaxone-Resistant Gonorrhea — China, 2022 · Xiaoyu Zhu · 2024 · 67 citations · Cited by this paper
  22. Antimicrobial-resistant Neisseria gonorrhoeae in Europe in 2020 compared with in 2013 and 2018: a retrospective genomic surveillance study · Daniel Golparian · 2024 · 59 citations · Cited by this paper
  23. Ceftriaxone-resistant Neisseria gonorrhoeae detected in England, 2015–24: an observational analysis · Helen Fifer · 2024 · 53 citations · Cited by this paper
  24. The Enhanced Gonococcal Surveillance Programme, Cambodia · Vichea Ouk · 2023 · 49 citations · Cited by this paper
  25. High prevalence of ceftriaxone-resistant and XDR Neisseria gonorrhoeae in several cities of Cambodia, 2022–23: WHO Enhanced Gonococcal Antimicrobial Surveillance Programme (EGASP) · Vara Ouk · 2024 · 49 citations · Cited by this paper
  26. Global Transmission of the penA Allele 60.001–Containing High-Level Ceftriaxone-Resistant Gonococcal FC428 Clone and Antimicrobial Therapy of Associated Cases: A Review · Stijn van der Veen · 2023 · 47 citations · Cited by this paper
  27. The novel 2024 WHO Neisseria gonorrhoeae reference strains for global quality assurance of laboratory investigations and superseded WHO N. gonorrhoeae reference strains—phenotypic, genetic and reference genome characterization · Magnus Unemo · 2024 · 45 citations · Cited by this paper
  28. Zoliflodacin versus ceftriaxone plus azithromycin for treatment of uncomplicated urogenital gonorrhoea: an international, randomised, controlled, open-label, phase 3, non-inferiority clinical trial · Alison Luckey · 2025 · 45 citations · Cited by this paper
  29. Antibiotics’ Use in Thailand: Community Pharmacists’ Knowledge, Attitudes and Practices · Budh Siltrakool · 2021 · 44 citations · Cited by this paper
  30. GyrB in silico mining in 27 151 global gonococcal genomes from 1928–2021 combined with zoliflodacin in vitro testing of 71 international gonococcal isolates with different GyrB, ParC and ParE substitutions confirms high susceptibility · Daniel Golparian · 2022 · 35 citations · Cited by this paper
  31. WHO global gonococcal antimicrobial surveillance programmes, 2019–22: a retrospective observational study · Magnus Unemo · 2025 · 32 citations · Cited by this paper
  32. British Association of Sexual Health and HIV UK National Guideline for the Management of infection with Neisseria gonorrhoeae , 2025 · Helen Fifer · 2025 · 31 citations · Cited by this paper
  33. The WHO Enhanced Gonococcal Antimicrobial Surveillance Programme (EGASP) identifies high levels of ceftriaxone resistance across Vietnam, 2023 · Phạm Thị Lan · 2024 · 27 citations · Cited by this paper
  34. Pharmacodynamic evaluation of ceftriaxone single-dose therapy (0.125–1 g) to eradicate ceftriaxone-susceptible and ceftriaxone-resistant Neisseria gonorrhoeae strains in a hollow fibre infection model for gonorrhoea · Magnus Unemo · 2024 · 15 citations · Cited by this paper
  35. High susceptibility to the novel antimicrobial zoliflodacin among Neisseria gonorrhoeae isolates in eight WHO Enhanced Gonococcal Antimicrobial Surveillance Programme countries in three WHO regions, 2021-2024 · Susanne Jacobsson · 2025 · 12 citations · Cited by this paper
  36. Antimicrobial resistance in Neisseria gonorrhoeae in nine sentinel countries within the World Health Organization Enhanced Gonococcal Antimicrobial Surveillance Programme (EGASP), 2023: a retrospective observational study · Ismaël Maatouk · 2025 · 12 citations · Cited by this paper
  37. Emergence, evolution and temporal spread of ceftriaxone-resistant Neisseria gonorrhoeae in China from 2002 to 2022: a retrospective genomic surveillance study · Chi Zhang · 2025 · 9 citations · Cited by this paper
  38. Neisseria gonorrhoeae antimicrobial susceptibility trends in Bangkok, Thailand, 2015–21: Enhanced Gonococcal Antimicrobial Surveillance Programme (EGASP) · Rossaphorn Kittiyaowamarn · 2023 · 8 citations · Cited by this paper
  39. Microbiological analysis and whole-genome sequencing of Neisseria gonorrhoeae from the microbiological failures in the international, zoliflodacin, phase 3, clinical trial for treatment of uncomplicated urogenital gonorrhoea: a retrospective, genomic, observational study · Magnus Unemo · 2026 · 6 citations · Cited by this paper

Source: OpenAlex (CC0)